What's in Tarsus Pharmaceuticals, Inc.'s pipeline?

Tarsus Pharmaceuticals, Inc. has 5 drugs in our index: 1 marketed, 0 filed, 2 in Phase 3, 2 in Phase 2, 0 in Phase 1.

Which companies overlap with Tarsus Pharmaceuticals, Inc.'s portfolio?

Top competitors by shared drug class: Agomab Spain S.L., Avalo Therapeutics, Inc., Bristol-Myers Squibb, Celltrion, Centocor, Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/tarsus-pharmaceuticals-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Tarsus Pharmaceuticals, Inc. — Portfolio Competitive Intelligence Brief

Tarsus Pharmaceuticals, Inc. pipeline: 1 marketed, 0 filed, 2 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 2 Phase 3 2 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Lotilaner ophthalmic solution, 0.25%	Lotilaner ophthalmic solution, 0.25%	marketed	Sigma receptor antagonist	Sigma receptors (non-selective)	Ophthalmology
TP-03	TP-03	phase 3	monoclonal antibody	CD40	Ophthalmology
TP-03 Vehicle	TP-03 Vehicle	phase 3			Ophthalmology

Therapeutic area mix

Ophthalmology · 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Agomab Spain S.L. · 1 shared drug class
Avalo Therapeutics, Inc. · 1 shared drug class
Bristol-Myers Squibb · 1 shared drug class
Celltrion · 1 shared drug class
Centocor, Inc. · 1 shared drug class
Clinique des Céphalées de Montréal · 1 shared drug class
Dermira, Inc. · 1 shared drug class
European Organisation for Research and Treatment of Cancer - EORTC · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Tarsus Pharmaceuticals, Inc.:

Cite this brief

Drug Landscape (2026). Tarsus Pharmaceuticals, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/tarsus-pharmaceuticals-inc. Accessed 2026-05-16.